Europe’s tech sector has spent years watching its most promising startups either stay private forever or hop across the Atlantic to list in New York. A deep pipeline of privately held technology companies is gearing up for IPOs that could inject billions into European stock exchanges.

The numbers already tell the story. EMEA IPO proceeds hit $7.4 billion across 34 deals in Q1 2026, a 30% jump compared to the same period last year. European listings specifically raised roughly 4.7 billion euros across 12 deals, up 47% year-over-year.

The candidates everyone is watching

Revolut, the London-headquartered fintech giant, carries a 95% IPO probability according to analyst ratings and may pursue a dual listing in 2026. Zopa, the UK digital bank, has the highest IPO probability of any company in the pipeline at 97%. Zopa has been profitable since 2024. Oura, the Finnish healthtech company best known for its smart ring, is targeting $2 billion in sales for 2026 and carries a 96% IPO probability. Bolt, the Estonian transportation platform, and Celonis, the Munich-based process mining software company, both carry IPO probabilities of 95% or higher.

Why now, and why it matters

Two forces are converging to make 2026 the year Europe’s tech IPO window finally opens wide. The first is interest rates. Central banks have been cutting, and declining rates make equities more attractive relative to bonds. The second force is maturation. Many of these companies have reached critical profitability milestones, and the venture capital firms and growth equity funds that backed them early are seeking liquidity events.

The Q1 2026 numbers were somewhat inflated by a single $3.9 billion defense sector deal, which means the tech-specific contribution to that $7.4 billion EMEA total was more modest. The pipeline building for the second half of 2026 is overwhelmingly tech-weighted, spanning fintech, SaaS, and healthtech.

What this means for investors

The risks are real. Geopolitical uncertainty hasn’t evaporated just because IPO proceeds are up. IPO windows have a habit of slamming shut without warning, and companies that delay too long could find themselves stuck in private markets for another cycle.

There’s also the question of valuation. Private market valuations for these companies were set during frothy funding rounds, and public markets may not agree with those numbers. If companies like Zopa or Celonis price their IPOs at significant discounts to their last private valuations, it could signal market caution despite the headline optimism. If they price at or above, that signals genuine demand.